Cell No. : Cell Name
RCB5658 : HeLa PMP2 KO
update : 2024/11/11
|
Comment | |
Comment from the depositor | PMP2-knockout HeLa cells were generated with CRISPR/Cas9 gene editing. |
Terms and conditions | 1) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. 2) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Cell Rep 2021 37(6):109935) designated by the DEPOSITOR is required.
|
Remarks | CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology. |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0065.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
SAKO, Yasushi
|
Originator |
SAKO, Yasushi
|
Year of deposit |
2022
|
Original cell |
HeLa
|
Animal |
_human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Gender |
Female
|
Age at sampling |
31 years
|
Tissue |
cervix
|
Primary focus |
cervical carcinoma
|
Classification |
cancer
|
Recombinant |
recombinant
|
|
Lifespan |
infinite
|
Morphology |
epithelial-like
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
Adherent cells
|
Adherent cells
|
Culture medium |
DMEM + 10% FBS
|
DMEM (low glucose) + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 10-20 split
|
SC frequency |
|
Subculture : 2 times/week
|
Temperature |
37
℃
|
37
℃
|
CO2 concentration |
5
%
|
5
%
|
Freeze medium |
Medium + 10% DMSO
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Acholeplasma |
|
(-)
|
Animal PCR |
|
OK
|
STR(human) |
|
OK
|
Reference information |
Reference |
1
|
User's Publication |
0
|